Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT07422181

PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.

Led by Maxima Medical Center · Updated on 2026-02-19

5

Participants Needed

1

Research Sites

28 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

During pregnancy, unique blood vessels form within the uterine wall, known as spiral arteries. These vessels originate from the uterine artery, which is the main artery supplying blood to the uterus. Throughout pregnancy, spiral arteries undergo significant changes to increase blood and oxygen flow to the placenta, ensuring the developing baby receives adequate nutrients. When these arteries fail to remodel properly, complications such as pre-eclampsia or fetal growth restriction can occur. Until now, direct observation and evaluation of spiral arteries during pregnancy has not been feasible. Contrast-enhanced ultrasound may provide a breakthrough in this area. In this study, the investigators aim to use this imaging technique to visualize spiral arteries after the placenta has been delivered. If successful, this could allow to assess their structural quality. Additionally, the investigators will employ ultrasound to monitor physiological changes in the uterine artery during late pregnancy (after 37 weeks), during labour, and postpartum. By conducting these measurements, the investigators hope to develop methods for detecting spiral artery abnormalities earlier in pregnancy. Early identification could enable timely interventions and help prevent severe complications.

CONDITIONS

Official Title

PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Pregnant patient aged 18 years or older
  • Singleton pregnancy at term (≥37 weeks gestation)
  • Planning to deliver at the Máxima Medical Centre
  • Able to provide informed consent
  • Intravenous access present at the time of delivery
Not Eligible

You will not qualify if you...

  • Multiple gestation pregnancy
  • Known allergy to SonoVue or its components
  • Planning on breastfeeding
  • Medical emergency during or after delivery making CEUS impossible or undesirable
  • No intravenous access available at the time of delivery
  • Body Mass Index greater than 40 kg/m2
  • Pre-eclampsia requiring medication
  • Fetal growth restriction below the 3rd percentile

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Máxima Medical center

Veldhoven, Netherlands, 5504DB

Actively Recruiting

Loading map...

Research Team

E

Eveline Dekker, Drs

CONTACT

L

Loes Monen, Dr.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here